EMA updates guidance on clinical studies for insomnia drugs
This article was originally published in SRA
Executive Summary
The European Medicines Agency has issued updated guidance on how companies developing medicines for treating insomnia should carry out clinical studies to increase their chances of gaining market authorisation.